Devarapu, S. K., Kumar VR, S., Rupanagudi, K. V., Kulkarni, O. P., Eulberg, D., Klussmann, S., & Anders, H. (2016). Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis. Clinical Immunology, 169, 139. https://doi.org/10.1016/j.clim.2016.07.003
Chicago Style (17th ed.) CitationDevarapu, Satish Kumar, Santhosh Kumar VR, Khader Valli Rupanagudi, Onkar P. Kulkarni, Dirk Eulberg, Sven Klussmann, and Hans-Joachim Anders. "Dual Blockade of the Pro-inflammatory Chemokine CCL2 and the Homeostatic Chemokine CXCL12 Is as Effective as High Dose Cyclophosphamide in Murine Proliferative Lupus Nephritis." Clinical Immunology 169 (2016): 139. https://doi.org/10.1016/j.clim.2016.07.003.
MLA (9th ed.) CitationDevarapu, Satish Kumar, et al. "Dual Blockade of the Pro-inflammatory Chemokine CCL2 and the Homeostatic Chemokine CXCL12 Is as Effective as High Dose Cyclophosphamide in Murine Proliferative Lupus Nephritis." Clinical Immunology, vol. 169, 2016, p. 139, https://doi.org/10.1016/j.clim.2016.07.003.
